A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight
NCT05726227 · Active, not recruiting
Last updated 2026-05-28This study is testing whether the medication semaglutide helps children and teenagers with obesity lose weight.
What this study is testing ClinicalTrials.gov NCT05726227 ↗
Description as written by the study sponsor.
This study will look at how well semaglutide helps children and teenagers losing weight. This will be tested by comparing the effect on body weight in children and teenagers taking semaglutide in comparison to placebo, a "dummy" medicine. In addition to taking the medicine, the child's parent and the child will have talks with study staff about healthy food choices, how to be more physically active and what your child can do to try to lose weight. The child will either get semaglutide or a "dummy" medicine. Which treatment the child will get is decided by chance. Semaglutide is an approved medicine for type 2 diabetes and weight management in adults. The child will get one injection once a week. The study medicine is injected with a thin needle in the stomach, thighs or upper arms. The study will last for about 2 ½ years (132 weeks).
Treatments tested
- Semaglutide Drug
Semaglutide will be administered subcutaneously once weekly.
- Placebo Drug
Placebo will be administered subcutaneously once-weekly.
| Main thing measured | Group Kids: Change in body mass index (BMI) |
|---|---|
| Sponsor | Novo Nordisk A/S |
| Conditions studied | Obesity |
| GLP-1 drugs | semaglutide |
Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT05726227 ↗